Adynxx

Adynxx Debt

The Debt of Adynxx (ADYX) as of Nov 22, 2026 is 8,733.00 USD. In the previous year, Debt was 10.93 M USD — a change of -99.92% (lower).

Debt

8,733.00USD

YoY

-99.92%

Last updated:

In 2018, Adynxx's total debt was 8,733.00 USD, a -99.92% change from the 10.93 M USD total debt recorded in the previous year.

The Adynxx Debt history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Debt
Date
Debt
Jan 1, 2014
1.99 M USD
Jan 1, 2015
12.13 M USD
Jan 1, 2016
11.54 M USD
Jan 1, 2017
10.93 M USD
Jan 1, 2018
8,733.00 USD
The Adynxx Debt history
YEARDebtYoY
8,733.00USD-99.92%
10.93 MUSD-5.30%
11.54 MUSD-4.82%
12.13 MUSD+509.55%
1.99 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Adynxx Stock analysis

What does Adynxx do? Adynxx Inc. is a biotechnology company focused on the development of novel, non-opioid-based pain therapies. The company was founded in 2007 in San Francisco, California, and has since pursued ambitious goals in the field of pain treatment. Adynxx has raised over $65 million in investments since its inception and has an experienced team of experts from the pharmaceutical industry, academic researchers, and business professionals. The company's business model is based on offering non-opioid pain therapy based on the blocking of the Kv1.7 protein. Adynxx aims to use this therapy in various areas such as surgery, acute pain management, and chronic pain treatment. The company employs an agile approach to clinical studies, allowing for quick adaptation to new insights and optimization of the effectiveness and safety of pain treatment. Adynxx operates in three areas: surgery, acute pain management, and chronic pain. Each division aims to provide pain patients with an effective alternative to opioid-based pain medications. The product line includes various non-opioid analgesics based on the blocking of the Kv1.7 protein. The flagship product, AYX1, is currently in Phase II clinical trials. It is an injection administered before or during surgery to relieve pain and offers up to 72 hours of pain relief. Another product in development is AYX2, intended for the treatment of chronic pain. Adynxx has the potential to fundamentally change pain treatment and provide a safe alternative to opioid-based pain medications, offering pain patients effective, safe, and sustainable relief and contributing to an improvement in quality of life. Adynxx is one of the most popular companies on Eulerpool.

Debt Details

Understanding Adynxx's Debt Structure

Adynxx's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing Adynxx's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to Adynxx’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in Adynxx’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about Adynxx stock

Debt of Adynxx is 8,733.00 USD in 2018.

Debt of Adynxx changed from 10.93 M USD to 8,733.00 USD, representing a -99.92% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Debt Adynxx since 2006 – with annual values, charts, and detailed analysis.

Debt's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Debt's Adynxx historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Adynxx

All Key Metrics — Adynxx